|
1
|
Chng KR, Chan SH, Ng AHQ, Li C, Jusakul A,
Bertrand D, Wilm A, Choo SP, Tan DMY, Lim KH, et al: Tissue
microbiome profiling identifies an enrichment of specific enteric
bacteria in opisthorchis viverrini associated cholangiocarcinoma.
EBioMedicine. 8:195–202. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verathamjamras C, Weeraphan C,
Chokchaichamnankit D, Watcharatanyatip K, Subhasitanont P,
Diskul-Na-Ayudthaya P, Mingkwan K, Luevisadpaibul V,
Chutipongtanate S, Champattanachai V, et al: Secretomic profiling
of cells from hollow fiber bioreactor reveals PSMA3 as a potential
cholangiocarcinoma biomarker. Int J Oncol. 51:269–280. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rizvi S, Khan SA, Hallemeier CL, Kelley RK
and Gores GJ: Cholangiocarcinoma-evolving concepts and therapeutic
strategies. Nat Rev Clin Oncol. 15:95–111. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou G, Yang Z, Wang X, Tao R and Zhou Y:
TRAIL enhances shikonin induced apoptosis through ROS/JNK signaling
in cholangiocarcinoma cells. Cell Physiol Biochem. 42:1073–1086.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mustafa MZ, Nguyen VH, Le Naour F, De
Martin E, Beleoken E, Guettier C, Johanet C, Samuel D,
Duclos-Vallee JC and Ballot E: Autoantibody signatures defined by
serological proteome analysis in sera from patients with
cholangiocarcinoma. J Transl Med. 14:172016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su Z, Liu G, Fang T, Zhang K, Yang S,
Zhang H, Wang Y, Lv Z and Liu J: Expression and prognostic value of
glutamate dehydrogenase in extrahepatic cholangiocarcinoma
patients. Am J Transl Res. 9:2106–2118. 2017.PubMed/NCBI
|
|
7
|
Saha SK, Zhu AX, Fuchs CS and Brooks GA:
Forty-year trends in cholangiocarcinoma incidence in the U.S.:
Intrahepatic disease on the rise. Oncologist. 21:594–599. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji W, Jiao J, Cheng C and Shao J:
MicroRNA-21 in the pathogenesis of traumatic brain injury.
Neurochem Res. 43:1863–1868. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang X, Hu S, Liu Q, Qian C, Liu Z and
Luo D: Exosomal microRNA remodels the tumor microenvironment.
PeerJ. 5:e41962017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sun X, Wang M, Liu H and Wang J:
MicroRNA-423 enhances the invasiveness of hepatocellular carcinoma
via regulation of BRMS1. Am J Transl Res. 9:5576–5584.
2017.PubMed/NCBI
|
|
11
|
Wei Q, Liu H, Ai Z, Wu Y, Liu Y, Shi Z,
Ren X and Guo Z: SC1 promotes MiR124-3p expression to maintain the
self-renewal of mouse embryonic stem cells by inhibiting the
MEK/ERK pathway. Cell Physiol Biochem. 44:2057–2072. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Othman N and Nagoor NH: miR-608 regulates
apoptosis in human lung adenocarcinoma via regulation of AKT2. Int
J Oncol. 51:1757–1764. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun C, Zhu J, Wu B, Chen J, Zhu Z, Cai P,
Guo W, Gu Z, Wang J and Huang S: Diagnostic and prognostic value of
microRNAs in cholangiocarcinoma: A systematic review and
meta-analysis. Cancer Manag Res. 10:2125–2139. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang Q, Liu L, Liu CH, You H, Shao F, Xie
F, Lin XS, Hu SY and Zhang CH: MicroRNA-21 regulates the invasion
and metastasis in cholangiocarcinoma and may be a potential
biomarker for cancer prognosis. Asian Pac J Cancer Prev.
14:829–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu YF, Li ZR, Cheng ZQ, Yin XM and Wu JS:
Decrease of miR-622 expression promoted the proliferation,
migration and invasion of cholangiocarcinoma cells by targeting
regulation of c-Myc. Biomed Pharmacother. 96:7–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Z, Shen J, Chan MT and Wu WK: The role
of microRNAs in intrahepatic cholangiocarcinoma. J Cell Mol Med.
21:177–184. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Reustle A, Fisel P, Renner O, Büttner F,
Winter S, Rausch S, Kruck S, Nies AT, Hennenlotter J, Scharpf M, et
al: Characterization of the breast cancer resistance protein
(BCRP/ABCG2) in clear cell renal cell carcinoma. Int J Cancer.
143:3181–3193. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Park JK, Doseff AI and Schmittgen TD:
MicroRNAs targeting caspase-3 and −7 in PANC-1 cells. Int J Mol
Sci. 19:E12062018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang T, Liu C, Huang S, Ma Y, Fang J and
Chen Y: A downmodulated microRNA profiling in patients with gastric
cancer. Gastroenterol Res Pract. 2017:15269812017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cai Y, Wang W, Guo H, Li H, Xiao Y and
Zhang Y: miR-9-5p, miR-124-3p, and miR-132-3p regulate BCL2L11 in
tuberous sclerosis complex angiomyolipoma. Lab Invest. 98:856–870.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Luo D, Sun H, Qi Y, Xu W, Jin X,
Li C, Lin Z and Li G: MiR-132-3p regulates ADAMTS-5 expression and
promotes chondrogenic differentiation of rat mesenchymal stem
cells. J Cell Biochem. 119:2579–2587. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leinonen R, Sugawara H and Shumway M;
International Nucleotide Sequence Database Collaboration, : The
sequence read archive. Nucleic Acids Res. 39:D19–D21. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parkinson H, Kapushesky M, Shojatalab M,
Abeygunawardena N, Coulson R, Farne A, Holloway E, Kolesnykov N,
Lilja P, Lukk M, et al: ArrayExpress-a public database of
microarray experiments and gene expression profiles. Nucleic Acids
Res. 35:D747–D750. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gan BL, He RQ, Zhang Y, Wei DM, Hu XH and
Chen G: Downregulation of HOXA3 in lung adenocarcinoma and its
relevant molecular mechanism analysed by RT-qPCR, TCGA and in
silico analysis. Int J Oncol. 53:1557–1579. 2018.PubMed/NCBI
|
|
27
|
Deng Y, He R, Zhang R, Gan B, Zhang Y,
Chen G and Hu X: The expression of HOXA13 in lung adenocarcinoma
and its clinical significance: A study based on the cancer genome
atlas, oncomine and reverse transcription-quantitative polymerase
chain reaction. Oncol Lett. 15:8556–8572. 2018.PubMed/NCBI
|
|
28
|
Liang YY, Huang JC, Tang RX, Chen WJ, Chen
P, Cen WL, Shi K, Gao L, Gao X, Liu AG, et al: Clinical value of
miR-198-5p in lung squamous cell carcinoma assessed using
microarray and RT-qPCR. World J Surg Oncol. 16:222018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nikolayeva O and Robinson MD: edgeR for
differential RNA-seq and ChIP-seq analysis: An application to stem
cell biology. Methods Mol Biol. 1150:45–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu YL, Rong XX, Wen LT, Zhu GX and Qian
MQ: miR-195 inhibits the proliferation and migration of
chondrocytes by targeting GIT1. Mol Med Rep. 15:194–200. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang N, Shen Q and Zhang P: miR-497
suppresses epithelial-mesenchymal transition and metastasis in
colorectal cancer cells by targeting fos-related antigen-1. Onco
Targets Ther. 9:6597–6604. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chi Y, Cui J, Wang Y, Du W, Chen F, Li Z,
Ma F, Song B, Xu F, Zhao Q, et al: Interferon-γ alters the microRNA
profile of umbilical cordderived mesenchymal stem cells. Mol Med
Rep. 14:4187–4197. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dweep H, Gretz N and Sticht C: miRWalk
database for miRNA-target interactions. Methods Mol Biol.
1182:289–305. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Vasaikar S, Shi Z, Greer M and
Zhang B: WebGestalt 2017: A more comprehensive, powerful, flexible
and interactive gene set enrichment analysis toolkit. Nucleic Acids
Res. 45:W130–W137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Z, Zhang G, Gao Z, Li S, Li Z, Bi J,
Liu X, Li Z and Kong C: Comprehensive analysis of differentially
expressed genes associated with PLK1 in bladder cancer. BMC Cancer.
17:8612017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zeng L, Yang K and Ge J: Uncovering the
pharmacological mechanism of astragalus salvia compound on
pregnancy-induced hypertension syndrome by a network pharmacology
approach. Sci Rep. 7:168492017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zeng L, Yang K, Liu H and Zhang G: A
network pharmacology approach to investigate the pharmacological
effects of Guizhi Fuling Wan on uterine fibroids. Exp Ther Med.
14:4697–4710. 2017.PubMed/NCBI
|
|
38
|
Wang A and Zhang G: Differential gene
expression analysis in glioblastoma cells and normal human brain
cells based on GEO database. Oncol Lett. 14:6040–6044.
2017.PubMed/NCBI
|
|
39
|
Su G, Morris JH, Demchak B and Bader GD:
Biological network exploration with Cytoscape 3. Curr Protoc
Bioinformatics. 47:8.13.1–24. 2014. View Article : Google Scholar
|
|
40
|
Colwill K; Renewable Protein Binder
Working Group, ; Gräslund S: A roadmap to generate renewable
protein binders to the human proteome. Nat Methods. 8:551–558.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Leinders M, Üçeyler N, Pritchard RA,
Sommer C and Sorkin LS: Increased miR-132-3p expression is
associated with chronic neuropathic pain. Exp Neurol. 283:276–286.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gu Y, Cai R, Zhang C, Xue Y, Pan Y, Wang J
and Zhang Z: miR-132-3p boosts caveolae-mediated transcellular
transport in glioma endothelial cells by targeting
PTEN/PI3K/PKB/Src/Cav-1 signaling pathway. FASEB J. 33:441–454.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Pichler S, Gu W, Hartl D, Gasparoni G,
Leidinger P, Keller A, Meese E, Mayhaus M, Hampel H and
Riemenschneider M: The miRNome of Alzheimer's disease: Consistent
downregulation of the miR-132/212 cluster. Neurobiol Aging. 50:167
e1–e167 e10. 2017. View Article : Google Scholar
|
|
44
|
Weber DG, Gawrych K, Casjens S, Brik A,
Lehnert M, Taeger D, Pesch B, Kollmeier J, Bauer TT, Johnen G and
Brüning T: Circulating miR-132-3p as a candidate diagnostic
biomarker for malignant mesothelioma. Dis Markers.
2017:92801702017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wu R, Li F, Zhu J, Tang R, Qi Q, Zhou X,
Li R, Wang W, Hua D and Chen W: A functional variant at miR-132-3p,
miR-212-3p, and miR-361-5p binding site in CD80 gene alters
susceptibility to gastric cancer in a Chinese Han population. Med
Oncol. 31:602014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li G, Liu K and Du X: Long non-coding RNA
TUG1 promotes proliferation and inhibits apoptosis of osteosarcoma
cells by sponging miR-132-3p and upregulating SOX4 expression.
Yonsei Med J. 59:226–235. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Song H, He P, Shao T, Li Y, Li J and Zhang
Y: Long non-coding RNA XIST functions as an oncogene in human
colorectal cancer by targeting miR-132-3p. J BUON. 22:696–703.
2017.PubMed/NCBI
|
|
48
|
Phanthaphol N, Techasen A, Loilome W,
Thongchot S, Thanan R, Sungkhamanon S, Khuntikeo N, Yongvanit P and
Namwat N: Upregulation of TCTP is associated with
cholangiocarcinoma progression and metastasis. Oncol Lett.
14:5973–5979. 2017.PubMed/NCBI
|
|
49
|
Sae-Lao T, Luplertlop N, Janvilisri T,
Tohtong R, Bates DO and Wongprasert K: Sulfated galactans from the
red seaweed Gracilaria fisheri exerts anti-migration effect on
cholangiocarcinoma cells. Phytomedicine. 36:59–67. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhu H, Jiang X, Zhou X, Dong X, Xie K,
Yang C, Jiang H, Sun X and Lu J: Neuropilin-1 regulated by miR-320
contributes to the growth and metastasis of cholangiocarcinoma
cells. Liver Int. 38:125–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Pak JH, Bashir Q, Kim IK, Hong SJ, Maeng
S, Bahk YY and Kim TS: Clonorchis sinensis excretory-secretory
products promote the migration and invasion of cholangiocarcinoma
cells by activating the integrin β4-FAK/Src signaling pathway. Mol
Biochem Parasitol. 214:1–9. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bian JL, Wang MM, Tong EJ, Sun J, Li M,
Miao ZB, Li YL, Zhu BH and Xu JJ: Benefit of everolimus in
treatment of an intrahepatic cholangiocarcinoma patient with a
PIK3CA mutation. World J Gastroenterol. 23:4311–4316. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Lyu SC, Han DD, Li XL, Ma J, Wu Q, Dong
HM, Bai C and He Q: Fyn knockdown inhibits migration and invasion
in cholangiocarcinoma through the activated AMPK/mTOR signaling
pathway. Oncol Lett. 15:2085–2090. 2018.PubMed/NCBI
|
|
54
|
Zhao X, Luo G, Cheng Y, Yu W, Chen R, Xiao
B, Xiang Y, Feng C, Fu W, Duan C, et al: Compound C induces
protective autophagy in human cholangiocarcinoma cells via
Akt/mTOR-independent pathway. J Cell Biochem. 119:5538–5550. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yokoi K, Kobayashi A, Motoyama H, Kitazawa
M, Shimizu A, Notake T, Yokoyama T, Matsumura T, Takeoka M and
Miyagawa SI: Survival pathway of cholangiocarcinoma via AKT/mTOR
signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib.
Oncol Rep. 39:843–850. 2018.PubMed/NCBI
|
|
56
|
Luo G, Li B, Duan C, Cheng Y, Xiao B, Yao
F, Wei M, Tao Q, Feng C, Xia X, et al: cMyc promotes
cholangiocarcinoma cells to overcome contact inhibition via the
mTOR pathway. Oncol Rep. 38:2498–2506. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Girgert R, Emons G and Gründker C:
Inhibition of growth hormone receptor by Somavert reduces
expression of GPER and prevents growth stimulation of
triple-negative breast cancer by 17β-estradiol. Oncol Lett.
15:9559–9566. 2018.PubMed/NCBI
|
|
58
|
Recouvreux MV, Wu JB, Gao AC, Zonis S,
Chesnokova V, Bhowmick N, Chung LW and Melmed S: Androgen receptor
regulation of local growth hormone in prostate cancer cells.
Endocrinology. 158:2255–2268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Heo MH, Kim HK, Lee H, Kim KM, Lee J, Park
SH, Park JO, Lim HY, Kang WK, Park YS and Kim ST: The clinical
impact of c-MET over-expression in advanced biliary tract cancer
(BTC). J Cancer. 8:1395–1399. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pei T, Li Y, Wang J, Wang H, Liang Y, Shi
H, Sun B, Yin D, Sun J, Song R, et al: YAP is a critical oncogene
in human cholangiocarcinoma. Oncotarget. 6:17206–17220. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wu L, Li Y, Li J and Ma D: MicroRNA-664
targets insulin receptor substrate 1 to suppress cell proliferation
and invasion in breast cancer. Oncol Res. 27:459–467. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Xu Y, Chen J, Gao C, Zhu D, Xu X, Wu C and
Jiang J: MicroRNA-497 inhibits tumor growth through targeting
insulin receptor substrate 1 in colorectal cancer. Oncol Lett.
14:6379–6386. 2017.PubMed/NCBI
|
|
63
|
Zhang J, Na S, Liu C, Pan S, Cai J and Qiu
J: MicroRNA-125b suppresses the epithelial-mesenchymal transition
and cell invasion by targeting ITGA9 in melanoma. Tumour Biol.
37:5941–5949. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Nawaz I, Hu LF, Du ZM, Moumad K, Ignatyev
I, Pavlova TV, Kashuba V, Almgren M, Zabarovsky ER and Ernberg I:
Integrin α9 gene promoter is hypermethylated and downregulated in
nasopharyngeal carcinoma. Oncotarget. 6:31493–31507. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Mostovich LA, Prudnikova TY, Kondratov AG,
Loginova D, Vavilov PV, Rykova VI, Sidorov SV, Pavlova TV, Kashuba
VI, Zabarovsky ER and Grigorieva EV: Integrin alpha9 (ITGA9)
expression and epigenetic silencing in human breast tumors. Cell
Adh Migr. 5:395–401. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ou J, Li J, Pan F, Xie G, Zhou Q, Huang H
and Liang H: Endostatin suppresses colorectal tumor-induced
lymphangiogenesis by inhibiting expression of fibronectin extra
domain A and integrin α9. J Cell Biochem. 112:2106–2114. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Okamoto K, Miyoshi K and Murawaki Y:
miR-29b, miR-205 and miR-221 enhance chemosensitivity to
gemcitabine in HuH28 human cholangiocarcinoma cells. PLoS One.
8:e776232013. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Sandhu V, Bowitz Lothe IM, Labori KJ,
Lingjærde OC, Buanes T, Dalsgaard AM, Skrede ML, Hamfjord J,
Haaland T, Eide TJ, et al: Molecular signatures of mRNAs and miRNAs
as prognostic biomarkers in pancreatobiliary and intestinal types
of periampullary adenocarcinomas. Mol Oncol. 9:758–771. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kojima M, Sudo H, Kawauchi J, Takizawa S,
Kondou S, Nobumasa H and Ochiai A: MicroRNA markers for the
diagnosis of pancreatic and biliary-tract cancers. PLoS One.
10:e01182202015. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Murakami Y, Kubo S, Tamori A, Itami S,
Kawamura E, Iwaisako K, Ikeda K, Kawada N, Ochiya T and Taguchi YH:
Comprehensive analysis of transcriptome and metabolome analysis in
intrahepatic cholangiocarcinoma and hepatocellular carcinoma. Sci
Rep. 5:162942015. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Plieskatt JL, Rinaldi G, Feng Y, Peng J,
Yonglitthipagon P, Easley S, Laha T, Pairojkul C, Bhudhisawasdi V,
Sripa B, et al: Distinct miRNA signatures associate with subtypes
of cholangiocarcinoma from infection with the tumourigenic liver
fluke opisthorchis viverrini. J Hepatol. 61:850–858. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Peng F, Jiang J, Yu Y, Tian R, Guo X, Li
X, Shen M, Xu M, Zhu F, Shi C, et al: Direct targeting of
SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma
tumourigenesis and metastasis. Br J Cancer. 109:3092–3104. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Oishi N, Kumar MR, Roessler S, Ji J,
Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, et al:
Transcriptomic profiling reveals hepatic stem-like gene signatures
and interplay of miR-200c and epithelial-mesenchymal transition in
intrahepatic cholangiocarcinoma. Hepatology. 56:1792–1803. 2012.
View Article : Google Scholar : PubMed/NCBI
|
